The involved proinflammatory markers include major cytokines, such as interleukin 1β (IL-1β), tumor necrosis factor-alpha (TNF-α) and prostaglandin E2 (PGE2), which are all majorly upregulated in DM patients’ GCF compared to non-DM patients. The gene discussed is IL1B; the disease is diabetes mellitus.